NordicBio - Circular Nordic Bio Nonwoven in MedTech Applications

Reference number
Coordinator Innovatum AB
Funding from Vinnova SEK 1 150 000
Project duration September 2018 - March 2021
Status Ongoing
Venture The strategic innovation programme Bioinnovation
Call Key Enabling Technologies for production of biobased products

Purpose and goal

The main purpose is to develop a material flow of nonwoven based medtech applications that can be demonstrated to be cost effective, both bio- and circular economy wise. The projects ambition is to successfully analyze, test and develop yarn- and garment production technologies using a combination of plant bases textile fibers and shredded post consumer textile waste, which does not exist on the market today. One overall goal is to enable scaling and commercialization of project results after its completion.

Expected results and effects

The project should, after its completion, have demonstrated at least one working process which also equals the expected commercialized innovation. The long term effect of a successful project outcome is that new technologies will be widely spread not only in healthcare, but also pharmaceutical, cosmetics and food industries. The project will communicate to a wide audience including industry, academia, government and the general public, all for a better tomorrow and a more sustainible future.

Planned approach and implementation

The project is based on a number of ideas and projects derived from SLL Innovation´s project portfolio. These have been linked with external entrepreneurship and strong innovative material companies, technology companies and research institutes. Project methodology will build a lot on iterative processes with an active customer. The project is based on a timetable where a number of phases are identified, which, in turn, provide a systematic and clarity to the process within the project.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.